Sort

Search

01/12/2023 Predictors of Response to Treatment with First-Generation Somatostatin Receptor Ligands in Patients with Acromegaly
Marques-Pamies, M, Gil, J, Jordà, M, Puig-Domingo, M. Predictors of Response to Treatment with First-Generation Somatostatin Receptor Ligands in Patients with Acromegaly. ARCHIVES OF MEDICAL RESEARCH. 2023; 54(8)DOI:10.1016/j.arcmed.2023.102924. PMID:38042683. IF:4.700(Q1/3D).
01/12/2023 Splanchnic Vein Thrombosis in Inflammatory Bowel Disease: An Observational Study from the ENEIDA Registry and Systematic Review
Puig, M, Masnou, H, Mesonero, F, Menchén, L, Bujanda, L, Castro, J, González-Partida, I, Vicente, R, González-Muoñza, C, Iborra, M, Sierra, M, Huguet, JM, García, MJ, De Francisco, R, García-Alonso, FJ, Mañosa, M, Domènech, E. Splanchnic Vein Thrombosis in Inflammatory Bowel Disease: An Observational Study from the ENEIDA Registry and Systematic Review. Journal of Clinical Medicine. 2023; 12(23)DOI:10.3390/jcm12237366. PMID:38068418. IF:3.000(Q1/2D).
01/12/2023 Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis
Balsa A., Díaz del Campo Fontecha P., Silva Fernández L., Valencia Martín J., Nistal Martínez V., León Vázquez F., Hernández Hernández M.V., Corominas H., Cáliz Cáliz R., Aguado García J.M., Candelas Rodríguez G., Ibargoyen Roteta N., Martí Carbajal A., Plana Farras M.N., Puñal Riobóo J., Park H.S., Triñanes Pego Y., Villaverde García V.. Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis. Reumatologia Clinica. 2023; 19(10)DOI:10.1016/j.reuma.2023.07.001. PMID:. IF:(Q/D).
01/12/2023 Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis.
Balsa A, Díaz Del Campo Fontecha P, Silva Fernández L, Valencia Martín J, Nistal Martínez V, León Vázquez F, Hernández Hernández MV, Corominas H, Cáliz Cáliz R, Aguado García JM, Candelas Rodríguez G, Ibargoyen Roteta N, Martí Carvajal A, Plana Farras MN, Puñal Riobóo J, Park HS, Triñanes Pego Y, Villaverde García V. Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis.. Reumatologia Clinica. 2023; 19(10)DOI:10.1016/j.reumae.2023.07.004. PMID:38008602. IF:(Q/D).